Search
Trichophyton tonsurans
go.drugbank.com/drugs/DB10970ApprovedTrichophyton tonsurans is a fungus which can provoke allergic reactions. Trichophyton tonsurans extract is used in allergenic testing.
Categories: Non-Standardized Fungal Allergenic ExtractThyme
go.drugbank.com/drugs/DB10983ApprovedThyme allergenic extract is used in allergenic testing.
Categories: Non-Standardized Food Allergenic ExtractUlmus rubra pollen
go.drugbank.com/drugs/DB10985ApprovedUlmus rubra pollen allergenic extract is used in allergenic testing.
Categories: Non-Standardized Pollen Allergenic ExtractPseudotsuga menziesii pollen
go.drugbank.com/drugs/DB10986ApprovedPseudotsuga menziesii pollen is the pollen of the Pseudotsuga menziesii plant. Pseudotsuga menziesii pollen is mainly used in allergenic testing.
Categories: Non-Standardized Pollen Allergenic ExtractMaclura pomifera pollen
go.drugbank.com/drugs/DB10988ApprovedMaclura pomifera pollen is the pollen of the Maclura pomifera plant. Maclura pomifera pollen is mainly used in allergenic testing.
Categories: Non-Standardized Pollen Allergenic ExtractFusarium graminearum
go.drugbank.com/drugs/DB13907ApprovedFusarium graminearum allergenic extract is used in allergenic testing.
Categories: Non-Standardized Fungal Allergenic ExtractMucor circinelloides f. lusitanicus
go.drugbank.com/drugs/DB15525ApprovedMucor circinelloides f. lusitanicus allergenic extract is used in allergenic testing.
Categories: Non-Standardized Fungal Allergenic ExtractAtinumab
go.drugbank.com/drugs/DB17923InvestigationalATI-355 is a humanized anti-Nogo-A antibody developed by Novartis.
Cyclopropane mycolic acid synthase 1
go.drugbank.com/bio_entities/BE0003738TargetMycobacterium tuberculosisCatalyzes the conversion of a double bond to a cyclopropane ring at the distal position of an alpha mycolic acid via the transfer of a methylene group from S-adenosyl-L-methionine. Cyclopropanated mycolic acids are key factors participat...
Synonyms: SAM-MTXentuzumab
go.drugbank.com/drugs/DB14871InvestigationalXentuzumab is under investigation in clinical trial NCT02191891 (Xentuzumab (BI 836845) Plus Afatinib in Patients With Epidermal Growth Factor Receptor (EGFR) Mutant Non-small Cell Lung Cancer (NSCLC))